Arcturus Therapeutics to present Phase 2 OTC deficiency data
Tweet Send to a Friend
Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) announced it will host a virtual presentation on September 23, 2026, at 4:30 p.m ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


